Menu
Recruiting NCT07601841

Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function

No phase Interventional Sleep Phototherapy Glymphatic System Mitochondrial Dynamics

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Morning Bright Light Therapy, Negative Ion Generator Therapy.
Who it may be relevant to
Registry conditions: Sleep, Phototherapy, Glymphatic System, Mitochondrial Dynamics. Basic parameters: 18 years — 89 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Light Therapy to Improve Sleep in Veterans With TBI: Sleep-active Biomarkers and Glymphatic Function

Overview

This is a clinical trial designed to examine how improved sleep through morning bright light therapy is improving downstream key physiologic processes related to brain health, i.e., mitochondrial function, systemic inflammation, and glymphatic function. All proposed methodology is already approved in other IRB applications.

Interventions

  • Device Morning Bright Light Therapy
    Exposure to bright light shortly after waking.
  • Device Negative Ion Generator Therapy
    Exposure to negative ions shortly after waking.

Primary outcome measures

  • Define the profile of blood-based markers of systemic inflammation pre- vs post-MBLT. [Time frame: From pre-intervention to end of device use (Approximately 4 weeks).]
  • Define mitochondrial function (oxygen consumption rate via Seahorse) pre- vs. post-MBLT. [Time frame: From pre-intervention to end of device use (Approximately 4 weeks).]
  • Explore glymphatic function via novel multi-model non-contrast-based MRI pre- vs. post-MBLT. [Time frame: From pre-intervention to end of device use (Approximately 4 weeks).]

Eligibility criteria

All subjects must:

  • Male and female; any race; 18-89 years of age.
  • Be English speaking.\*
  • Be accessible via phone.
  • Be non-decisionally impaired. Determined by assessing the subject's ability to verbalize their understanding of the protocol back to us during the informed consent process.
  • Not have a history of macular degeneration.
  • Not have a history of bipolar disorder.
  • Not be currently using a lightbox or a negative ion generator.
  • Not be a shift worker.
  • Have a documented history of TBI via the Head Trauma Events Characteristics (HTEC) or OHIO conducted in accordance with VA/DoD Clinical Practice Guidelines.88
  • Present with self-reported sleep-wake disturbances.
  • Remain clinically stable for current pharmacologic treatment related to depression/anxiety, sleep, and pain.
  • MRI specific compatibility requirements:
  • No pacemaker, wires, defribrillator or implanted heart valves
  • No history of head surgery requiring aneurysm clips
  • No history of other orthopedic or general surgery requiring the implantation of ferrous pins, joints, electric devices/pumps, or other foreign metal objects
  • History of eye exposure to metal (unprotected welding/metalworking/shrapnel) is allowable provided the participant screens negative for metal in the eyes on an orbital x-ray or is able to provide clinical documentation of having screened negative.
  • No history of non-removable hearing aids, middle/inner ear prosthesis, or dentures
  • No history of claustrophobia; if unsure participant will be pre-screened in our mock scanner
  • Not currently pregnant, breastfeeding, or have an implanted IUD. Participants who are unsure of their pregnancy status will be administered an hCG urine pregnancy test the day of their scan.
  • Able to lay flat on their back comfortably without a thick pillow for an extended period of time.
  • Shoulder width does not exceed width for safety fitting in the MRI bore.
  • This study is limited to English-speaking participants because all assessments, interventions, and consent materials are currently validated and approved only in English. Expanding to other languages would require translation and psychometric validation, which are beyond the scope and budget of this study. This limitation is acknowledged and will be addressed in future research as resources permit. Finally, the study team is only fluent in English, making it infeasible to accurately consent or interact with non-English speakers without interpreting services which again is outside of the scope of this projects budget and timeline. Proceeding without formal translation services would risk miscommunication in informed consent, data collection, or participant support and thus protects participants informed consent and participant understanding.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Oregon Health and Science University — Portland

Identifiers

NCT: NCT07601841 · STUDY00028579 · TP240626

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗